Israel Chemicals Ltd (ICL)
5.83 +0.09 (+1.57%) 13:04 ET [NYSE]
5.82 x 263 5.83 x 100
Realtime by (Cboe BZX)
5.82 x 263 5.83 x 100
Realtime 5.70 -0.04 (-0.70%) 09:28 ET
for Thu, Mar 27th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2014 | 12-2013 | 12-2006 | |
Sales | 6,111,000 | 6,272,000 | 0 |
Cost of Goods | 3,915,000 | 3,862,000 | N/A |
Gross Profit | 2,196,000 | 2,410,000 | N/A |
Operating Expenses | 1,438,000 | 1,309,000 | 0 |
Operating Income | 758,000 | 1,101,000 | N/A |
Interest Expense | 279,000 | 158,000 | 0 |
Other Income | 153,000 | 158,000 | 0 |
Pre-tax Income | 632,000 | 1,101,000 | 0 |
Income Tax | 166,000 | 281,000 | N/A |
Net Income Continuous | 466,000 | 820,000 | N/A |
Minority Interests | 2,000 | 1,000 | N/A |
Net Income | $464,000 | $819,000 | $N/A |
EPS Basic Total Ops | 0.37 | 0.64 | N/A |
EPS Basic Continuous Ops | 0.37 | 0.65 | N/A |
EPS Diluted Total Ops | 0.37 | 0.64 | N/A |
EPS Diluted Continuous Ops | 0.37 | 0.65 | N/A |
EBITDA(a) | $1,185,000 | $1,449,000 | $N/A |